Covaxin effective, imp antidote against COVID-19, says Dr Anthony Fauci

Covaxin effective, important antidote against COVID-19, says Dr Anthony Fauci
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3
PTI | April 28, 2021 | Updated 09:24 IST
Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, White House chief medical adviser and America's top pandemic expert Dr Anthony Fauci said in Washington. Fauci was speaking to reporters during a conference call on Tuesday.
"This is something where we're still gaining data on a daily basis. But the most recent data, was looking at convalescent Sera of COVID-19 cases and people who received the vaccine used in India, the Covaxin. It was found to neutralise the 617 variant," he said.

Related Keywords

United States ,India ,Washington ,White House ,District Of Columbia ,America ,Bharat ,Andy Slavitt ,Anthony Fauci ,Pfizer ,Astrazeneca ,National Institute Of Virology ,Indian Council Of Medical Research ,Johnson ,New York Times ,Bharat Biotech ,National Institute ,Indian Council ,Medical Research ,Senior Advisor ,Disease Control ,Covaxin ,Covaxin Efficacy Rate ,Covaxin Effectiveness ,Covaxin Effective Against Covid 19 ,Bharat Biotech Covid 19 Vaccine ,White House Chief Medical Adviser ,America Top Pandemic Expert ,Dr Anthony Fauci ,Dr Andy Slavitt ,White House Covid 19 Respo ,ஒன்றுபட்டது மாநிலங்களில் ,இந்தியா ,வாஷிங்டன் ,வெள்ளை வீடு ,மாவட்டம் ஆஃப் கொலம்பியா ,அமெரிக்கா ,பாரத் ,ஃபைசர் ,தேசிய நிறுவனம் ஆஃப் வைராலஜி ,இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி ,ஜான்சன் ,புதியது யார்க் முறை ,பாரத் பயோடெக் ,தேசிய நிறுவனம் ,இந்தியன் சபை ,மருத்துவ ஆராய்ச்சி ,நோய் கட்டுப்பாடு ,